NO20076083L - Mukoadhesive xyloglukaninneholdende formuleringer som er anvendelige i medisinske anordninger og i farmasoytiske formuleringer - Google Patents

Mukoadhesive xyloglukaninneholdende formuleringer som er anvendelige i medisinske anordninger og i farmasoytiske formuleringer

Info

Publication number
NO20076083L
NO20076083L NO20076083A NO20076083A NO20076083L NO 20076083 L NO20076083 L NO 20076083L NO 20076083 A NO20076083 A NO 20076083A NO 20076083 A NO20076083 A NO 20076083A NO 20076083 L NO20076083 L NO 20076083L
Authority
NO
Norway
Prior art keywords
formulations
mucoadhesive
medical devices
xyloglucan
pharmaceutical
Prior art date
Application number
NO20076083A
Other languages
English (en)
Other versions
NO338991B1 (no
Inventor
Giuseppe Claudio Viscomi
Giuseppe Bottoni
Paola Maffei
Annalisa Sforzini
Mascia Federici
Carla Caramella
Silvia Rossi
Original Assignee
Alfa Wassermann Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alfa Wassermann Spa filed Critical Alfa Wassermann Spa
Publication of NO20076083L publication Critical patent/NO20076083L/no
Publication of NO338991B1 publication Critical patent/NO338991B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A61K31/416—1,2-Diazoles condensed with carbocyclic ring systems, e.g. indazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/23—Calcitonins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/14—Antitussive agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Otolaryngology (AREA)
  • Communicable Diseases (AREA)
  • Gynecology & Obstetrics (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Oncology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Endocrinology (AREA)
  • Zoology (AREA)
  • Pulmonology (AREA)
  • Inorganic Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Virology (AREA)

Abstract

Målet for oppfinnelsen er frigjøringsformuleringer med mukoadhesive og kontrollerte egenskaper bestående av vandige oppløsninger inneholdende 0,05 til 5 vekt% av en naturlig renset polymer med xyloglukanstruktur og 10 til 70 vekt% glyserol. Disse formuleringer er egnet til applikasjon på humane mukøse membraner så som nese, orale og vaginale mukøse membraner, som fuktende og mykgjørende midler eller som farmasøytisk frigjøringssystem. Ytterligere mål for oppfinnelsen er farmasøytiske formuleringer og medisinske anordninger som er egnet for applikasjon på humane mukøse membraner, inneholdende de mukoadhesive og kontrollerte frigjøringsformuleringer sammen med aktive bestanddeler og eksipienter. ?? ?? ?? ??
NO20076083A 2005-06-06 2007-11-26 Mukoadhesive xyloglukaninneholdende formuleringer som er anvendelige i medisinske anordninger og i farmasøytiske formuleringer NO338991B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT000388A ITBO20050388A1 (it) 2005-06-06 2005-06-06 Formulazione mucoadesive utili in dispositivi medici in preparazioni farmaceutiche
PCT/EP2006/005240 WO2006131262A1 (en) 2005-06-06 2006-06-01 Mucoadhesive xyloglucan-containing formulations useful in medical devices and in pharmaceutical formulations

Publications (2)

Publication Number Publication Date
NO20076083L true NO20076083L (no) 2007-11-26
NO338991B1 NO338991B1 (no) 2016-11-07

Family

ID=36954507

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20076083A NO338991B1 (no) 2005-06-06 2007-11-26 Mukoadhesive xyloglukaninneholdende formuleringer som er anvendelige i medisinske anordninger og i farmasøytiske formuleringer

Country Status (22)

Country Link
US (3) US20090081133A1 (no)
EP (1) EP1898876B1 (no)
JP (1) JP5118633B2 (no)
KR (1) KR101337578B1 (no)
CN (2) CN102079794B (no)
AT (1) ATE418324T1 (no)
BR (1) BRPI0611400B8 (no)
CA (1) CA2604768C (no)
CY (1) CY1108875T1 (no)
DE (1) DE602006004451D1 (no)
DK (1) DK1898876T3 (no)
ES (1) ES2318756T3 (no)
IL (1) IL186655A (no)
IT (1) ITBO20050388A1 (no)
MX (1) MX2007015074A (no)
NO (1) NO338991B1 (no)
PL (1) PL1898876T3 (no)
PT (1) PT1898876E (no)
RU (1) RU2403012C2 (no)
SI (1) SI1898876T1 (no)
UA (1) UA90507C2 (no)
WO (1) WO2006131262A1 (no)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT1698630E (pt) 2005-03-03 2014-09-15 Alfa Wassermann Spa Novas formas polimorfas de rifaximina, processos para a sua produção e a sua utilização nas preparações medicinais
US20090068122A1 (en) * 2007-09-06 2009-03-12 Shira Pilch Dentifrice Compositions for Treating Xerostomia
CN102026663A (zh) * 2008-04-11 2011-04-20 赛姆生物系统遗传公司 油质体中活性剂的控制释放
WO2010088191A1 (en) * 2009-01-27 2010-08-05 Teleflex Medical Incorporated Sputum dissolving suctioning solution for endotracheal and tracheostomy tubes
JP2011001317A (ja) * 2009-06-19 2011-01-06 Fumakilla Ltd 鼻用洗浄剤
IT1397132B1 (it) 2009-12-01 2013-01-04 Alfa Wassermann Spa Composizioni comprendenti antiinfiammatori non steroidei.
JP2013526594A (ja) 2010-05-24 2013-06-24 インデナ エッセ ピ ア 微生物感染の治療に使用するためのタマリンド種子多糖
CA2800383C (en) 2010-05-24 2019-06-25 Indena S.P.A. Tamarind seed polysaccharide for use in the treatment of inflammatory diseases
CN103189046B (zh) 2010-09-09 2016-09-07 玫琳凯有限公司 包含植物提取物的局部护肤制剂
US9301920B2 (en) 2012-06-18 2016-04-05 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
ES2885523T3 (es) 2011-11-23 2021-12-14 Therapeuticsmd Inc Formulaciones y terapias de reposición hormonal de combinación naturales
US9091622B2 (en) 2011-12-20 2015-07-28 Exxonmobil Upstream Research Company Capillary-based calibration standards for measurement of permeability
US20150196640A1 (en) 2012-06-18 2015-07-16 Therapeuticsmd, Inc. Progesterone formulations having a desirable pk profile
US20130338122A1 (en) 2012-06-18 2013-12-19 Therapeuticsmd, Inc. Transdermal hormone replacement therapies
US10806697B2 (en) 2012-12-21 2020-10-20 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10806740B2 (en) 2012-06-18 2020-10-20 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
CA2870170C (en) 2012-09-12 2018-06-12 Boston Scientific Scimed, Inc. Adhesive stent coating for anti-migration
US10537581B2 (en) 2012-12-21 2020-01-21 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11246875B2 (en) 2012-12-21 2022-02-15 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10471072B2 (en) 2012-12-21 2019-11-12 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US9180091B2 (en) 2012-12-21 2015-11-10 Therapeuticsmd, Inc. Soluble estradiol capsule for vaginal insertion
US10568891B2 (en) 2012-12-21 2020-02-25 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11266661B2 (en) 2012-12-21 2022-03-08 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
ITMI20130960A1 (it) * 2013-06-11 2014-12-12 Novintethical Pharma Sagl Composizioni a base di xiloglucano per il trattamento di disturbi gastrointestinali
US20150094266A1 (en) * 2013-06-11 2015-04-02 Novintethical Pharma, SA Xyloglucan and protein compositions for the treatment of intestinal disorders
ITMI20132103A1 (it) * 2013-12-16 2015-06-17 Novintethical Pharma Sagl Composizioni topiche nasali contenenti xiloglucani per uso come decongestionanti
CA2945631C (en) 2014-04-15 2023-04-11 Novintethical Pharma Sa Compositions based on xyloglucan and proteins for the treatment of intestinal disorders
MX2016014281A (es) 2014-05-22 2017-02-22 Therapeuticsmd Inc Formulaciones y terapias de reemplazo de combinación de hormonas naturales.
MX2016013693A (es) 2014-07-29 2017-10-31 Therapeuticsmd Inc Crema transdermica.
US11623008B2 (en) 2014-08-20 2023-04-11 Professional Compounding Centers Of America Excipient compositions for mucoadhesive pharmaceutical compositions including a synergistic combination of amylopectin, pullulan, hyaluronic acid, and xyloglucan
EP3103438B1 (en) 2015-06-11 2018-11-14 Novintethical Pharma SA Topical nasal compositions containing xyloglucans for use as decongestans
US10328087B2 (en) 2015-07-23 2019-06-25 Therapeuticsmd, Inc. Formulations for solubilizing hormones
AU2017239645A1 (en) 2016-04-01 2018-10-18 Therapeuticsmd, Inc. Steroid hormone pharmaceutical composition
US10286077B2 (en) 2016-04-01 2019-05-14 Therapeuticsmd, Inc. Steroid hormone compositions in medium chain oils
US10780146B2 (en) 2016-05-31 2020-09-22 Devintec Sagl Compositions for the treatment of intestinal disorders
WO2018007288A1 (en) * 2016-07-08 2018-01-11 Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F. S.P.A. Pharmaceutical composition comprising benzydamine
IT201700108526A1 (it) 2017-09-28 2019-03-28 Alfasigma Spa Composizioni orali per il trattamento del refluso gastroesofageo.
PT3986378T (pt) 2019-06-21 2026-02-18 Alfasigma Spa Composições farmacêuticas sob a forma de gel que contêm xiloglucano e álcoois para a libertação controlada de ingredientes ativos
IT202100010802A1 (it) 2021-05-03 2022-11-03 Alfasigma Spa Formulazione solida mucoadesiva comprendente probiotici per uso nella prevenzione e nel trattamento di disbiosi orale.
JP2023084941A (ja) * 2021-12-08 2023-06-20 Ｍｐ五協フード＆ケミカル株式会社 噴霧用組成物
CN114306237A (zh) * 2022-01-06 2022-04-12 江苏爱朋医疗科技股份有限公司 一种鼻腔护理喷雾剂及其制备方法和应用

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69012955T2 (de) * 1989-10-31 1995-02-09 Columbia Laboratories, Inc., Miami, Fla. Verfahren zur Feuchthaltung von Gewebe und Mittel dazu.
JPH07289179A (ja) * 1994-04-28 1995-11-07 Dainippon Pharmaceut Co Ltd 米飯用改質剤
US6271001B1 (en) * 1995-03-23 2001-08-07 Bio Polymers Pty. Ltd. Cultured plant cell gums for food, pharmaceutical, cosmetic and industrial applications
JP3909095B2 (ja) * 1995-04-11 2007-04-25 大日本住友製薬株式会社 可逆的熱ゲル化剤
IT1283911B1 (it) * 1996-02-05 1998-05-07 Farmigea Spa Soluzioni oftalmiche viscosizzate con polisaccaridi della gomma di tamarindo
JP4259613B2 (ja) * 1996-02-13 2009-04-30 大日本住友製薬株式会社 ガラクトキシログルカンを用いるドラッグ・デリバリー・システム
JPH11152207A (ja) * 1997-11-20 1999-06-08 Shiseido Co Ltd 化粧料
JPH10259142A (ja) * 1997-03-14 1998-09-29 Shiseido Co Ltd 化粧料
JP2001517493A (ja) * 1997-09-26 2001-10-09 ノーヴェン ファーマシューティカルズ インコーポレイテッド 生体接着剤組成物及び活性薬剤の局所投与方法
CN1226037C (zh) * 2001-05-03 2005-11-09 法米基股份公司 硫糖铝在制备治疗宫颈糜烂药物上的用途
DE10344126A1 (de) * 2003-09-24 2005-04-21 Henkel Kgaa Wasserlöslicher Schmelzklebstoff
US20050214230A1 (en) * 2004-03-23 2005-09-29 J. B. Chemicals & Pharmaceuticals Ltd. Novel stomatological gel

Also Published As

Publication number Publication date
WO2006131262A1 (en) 2006-12-14
BRPI0611400B8 (pt) 2021-05-25
BRPI0611400A8 (pt) 2017-12-26
ATE418324T1 (de) 2009-01-15
DK1898876T3 (da) 2009-03-02
PT1898876E (pt) 2009-03-05
EP1898876A1 (en) 2008-03-19
RU2403012C2 (ru) 2010-11-10
CN102079794A (zh) 2011-06-01
CA2604768C (en) 2013-07-30
CN101180036B (zh) 2011-07-27
RU2007143998A (ru) 2009-07-20
US20090081133A1 (en) 2009-03-26
UA90507C2 (uk) 2010-05-11
EP1898876B1 (en) 2008-12-24
JP5118633B2 (ja) 2013-01-16
NO338991B1 (no) 2016-11-07
CA2604768A1 (en) 2006-12-14
ES2318756T3 (es) 2009-05-01
US20130183325A1 (en) 2013-07-18
CN102079794B (zh) 2012-03-28
JP2008542324A (ja) 2008-11-27
IL186655A0 (en) 2008-01-20
SI1898876T1 (sl) 2009-04-30
PL1898876T3 (pl) 2009-06-30
US20120088726A1 (en) 2012-04-12
IL186655A (en) 2010-12-30
BRPI0611400A2 (pt) 2010-09-08
BRPI0611400B1 (pt) 2020-04-28
DE602006004451D1 (de) 2009-02-05
CY1108875T1 (el) 2014-07-02
KR101337578B1 (ko) 2013-12-09
KR20080016596A (ko) 2008-02-21
CN101180036A (zh) 2008-05-14
ITBO20050388A1 (it) 2006-12-07
MX2007015074A (es) 2008-01-24

Similar Documents

Publication Publication Date Title
NO20076083L (no) Mukoadhesive xyloglukaninneholdende formuleringer som er anvendelige i medisinske anordninger og i farmasoytiske formuleringer
NO20071354L (no) anvendelse av samme Butylftalid selvemulsifiserene medikamentavgivelsessystem, samt fremgangsmater for fremstilling og anvendelse av samme.
BR0011116A (pt) Usos de uma nsaid que libera no como um sal farmaceuticamente aceitável ou um enanciÈmero do mesmo, e de uma nsaid que libera no e de um inibidor de bomba de próton suscetìvel a ácido ou um sal do mesmo ou um enanciÈmero ou de um sal do enanciÈmero, método para o tratamento de uma infecção bacteriana, e, formulação farmacêutica adequada para uso no tratamento de infecções bacterianas
TR200003158T2 (tr) Jelleşebilen farmasötik bileşimler
DOP2000000114A (es) Oxazolidinonas substituidas y su uso
DK1079806T3 (da) Præparater til påföringen af antiinflammatoriske, især antiseptiske midler og/eller midler, der fremmer helingen af sår, til de övre luftveje og/eller öret
AR030068A1 (es) Composiciones farmaceuticas para el tratamiento de condiciones dolorosas, inflamatorias y ulcerosas de superficies epiteliales humedas como por ejemplo mucositis, estomatitis y sindrome de behcet
RU2013125021A (ru) Местные композиции для сохранения или восстановления целостности слизистых оболочек
PL373276A1 (en) Trans-epicutaneous administration form for treating restless leg syndrome
DE60120648D1 (de) Formulierungen von copolymer 1 (glatirameracetat) zur oralen, nasalen und pulmonalen verabreichung
ITMI20030195A1 (it) Formulazioni topiche contenenti principi attivi naturali adatte alla prevenzione e cura dei processi infiammatori delle mucose
DE602005021770D1 (de) Indol-1-yl-essigsäurederivate
BR9901782A (pt) Forma para dosagem de nefazodona.
BR0311460A (pt) Composição farmacêutica de liberação modificada, uso de uma formulação, e, método para tratar um distúrbio cardiovascular em um paciente
DK1401422T3 (da) Halogenholdig sammensætning, fremgangsmåde til fremstilling heraf og anvendelser heraf
CO7101247A2 (es) Formulaciones de ácido poliinosínico-policitidílico (poli(i:c)) para el tratamiento de infecciones de las vías respiratorias altas
PT1425005E (pt) Composicao farmaceutica que compreende lumiracoxib
FI20095606A7 (fi) Järjestelmä ja menetelmä alhaisen suspendoituneen kiintoainepitoisuuden omaavan liuoksen tuottamiseksi ja sellaisen liuoksen käyttö
DK1957037T3 (da) Farmaceutisk præparat til nasal anvendelse af fentanyl
BRPI0411702B8 (pt) uso de ácido hialurônico para preparar composições para o tratamento de aftas da cavidade oral
BR0206960A (pt) Composição farmacêutica oral, e, uso de um polìmero de ftalato de hidroxipropilmetilcelulose
BRPI0414223A (pt) uso de extratos de gentiana lutea como um agente antimicrobiano
ITMI20071051A1 (it) Composizione per il trattamento naturale e/o di sintesi, delle patologie infiammatorie batteriche o virali della gola, con presenza di xerostomia.
BR0205625C1 (pt) Formulações nasais em gel
BR0200291A (pt) Composição farmacêutica lìquida para o uso no tratamento de doenças ósseas, processo para preparar a mesma e processo para tratamento de uma doença óssea

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees